ID: ALA3349555

Max Phase: Preclinical

Molecular Formula: C6H13NO4

Molecular Weight: 163.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O[C@@H]1[C@H](O)[C@H](O)CNC[C@H]1O

Standard InChI:  InChI=1S/C6H13NO4/c8-3-1-7-2-4(9)6(11)5(3)10/h3-11H,1-2H2/t3-,4-,5-,6+/m1/s1

Standard InChI Key:  MRFFNLOQLBWKPJ-KAZBKCHUSA-N

Associated Targets(Human)

Alpha-L-fucosidase I 304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 163.17Molecular Weight (Monoisotopic): 163.0845AlogP: -2.97#Rotatable Bonds: 0
Polar Surface Area: 92.95Molecular Species: NEUTRALHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.72CX Basic pKa: 8.49CX LogP: -2.89CX LogD: -4.00
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.26Np Likeness Score: 1.15

References

1. Robina I, Moreno-Vargas AJ, Fernández-Bolaños JG, Fuentes J, Demange R, Vogel P..  (2001)  New leads for selective inhibitors of alpha-L-fucosidases. Synthesis and glycosidase inhibitory activities of [(2R,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]furan derivatives.,  11  (18): [PMID:11549468] [10.1016/s0960-894x(01)00497-8]

Source